Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 507)
Posted On: 09/08/2021 9:48:03 PM
Post# of 155570
Posted By: RTB
Re: HHIGambler #103013
HHIG - it seemed very clear that CD17 might (will) start tomorrow, but that they don't consider it the important trial of the two. It has 600+ patients, I think, and they didn't emphasize the interim analysis. They implied that our benefit on severe patients could be modest, so they needed a lot of patients.

On CD16, they were very clear that they thought the interim analysis (around 116 or 160?) patients could be dynamite. That was exciting.

But, they were much less clear on the start date. "hopefully next week." But, really, they are waiting for Anvisa to review the IV stability information that was recently submittted. So, that could go fast, or it could go slow.

Is that a fair recap on these two trials?













(0)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site